Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Quidel Corporation (QDEL)

NASDAQ
Currency in USD
Disclaimer
38.26
-0.45(-1.16%)
Closed
After Hours
38.260.00(0.00%)

QDEL Comments

not buying anymore 😭😂
again I bought from $69 🤣
bought some more from $78
last tree quarters they made over 1b profit p/e 3 price $85.66 all in thank you sellers 🤑🤑👏👏
under $100 stealing
The COVID test manufacturer price drops because of COVID fears.
Bogdanoff: Dump it!
WHKS had a sec investigaton announced today, but if dropped less, than qdel on good earnings report. Nice.
cup and handle?
breakout
Take. (115)
bought again 135.5 , after that added more on good news (141), waiting for next week events.
Sold 141. Ok.
I think you will buy again next month$170 :)
Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it is entering a partnership with the State of Delaware
kind of "safe" asset in case of covid threat increase.
Any news on this one 👀
the reason quidel goes down is access bio INC(950130) carestart covid antigen test sells very well
lol
lol selling this $104
overeaction. very good company, amazing growth. very nice discount.
Wow... what a dip! Not looking good.
Revenue misses estimate consensus (SeekingAlpha) -> Monkeyhammer!
most stocks are 52 weeks highs this one almost 52 weeks low who is selling$122 this one and buying 52 high stocks that's weird
I m down almostP down I don't mind P more down
I m down P I don't mind %5
it's okay I m down P I don't care %5
it's down %100 in 1,5 month is ceo still alive ?
“Quidel applauds the Biden Administration’s urgent and comprehensive approach to bringing the benefits of rapid, routine and equitable coronavirus testing to America’s classrooms, underserved communities and rural areas,” said Douglas Bryant, president and CEO of Quidel Corporation. “Frequent testing has proven to be a critical tool for both empowering people to take charge of their own health and allowing large institutions, businesses, sports and entertainment venues and enumerable other aspects of society to reopen safely and remain so.”
Quidel is currently building out a new manufacturing facility in Carlsbad, CA dedicated to the production of Quidel’s popular QuickVue® line of products. The 128,000 square foot facility will be the company’s highest-volume production plant in the world and is expected to produce 600 million QuickVue® rapid antigen tests for the detection and diagnosis of COVID-19 infections.
Time to buy for me...   ( JP Morgan Adjusts Price Target for Quidel to $120 From $140, Maintains Underweight Rating 03/11/2021 | 10:04am EST )
$$130 wowww still selling
$142 who is selling 🤣
🤣🤣 who is selling$153
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.